What is the management plan for a 32-year-old female with a normal Pap (Papanicolau) smear and positive Human Papillomavirus (HPV) status for non-high-risk types?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of a 32-year-old Female with Normal Pap and Non-High-Risk HPV Positive Status

For a 32-year-old female with normal Pap smear and positive HPV test for non-high-risk types (not 16,18, or 45), repeat HPV testing and cytology in 12 months is the recommended management approach. 1, 2

Understanding the Risk Profile

  • Non-high-risk HPV types have a significantly lower risk of progression to cervical intraepithelial neoplasia (CIN) compared to high-risk types like HPV 16 and 18 3
  • Despite the lower risk, follow-up is still necessary as HPV persistence is associated with increased risk of developing cervical abnormalities 4
  • Women with normal cytology but positive for HPV have approximately 116 times higher risk of developing CIN III compared to women negative for HPV, though this risk is substantially lower for non-high-risk types 5

Management Algorithm

Initial Management

  • Repeat co-testing (Pap and HPV) in 12 months 1, 2
  • No immediate colposcopy is indicated with normal cytology and non-high-risk HPV types 1
  • Treatment of any symptomatic vaginal infections if present, though this doesn't eliminate the need for follow-up testing 2

Follow-up Based on 12-Month Results

  • If both Pap and HPV negative at 12 months: Return to routine screening 1, 2
  • If HPV remains positive but Pap is negative: Repeat co-testing in 12 months or refer to colposcopy if HPV persistence is concerning 1
  • If Pap shows ASC-US or worse: Follow management guidelines for abnormal cytology results with colposcopy 1

Rationale for This Approach

  • The 12-month interval allows time to assess for viral clearance, which occurs in approximately 43% of women with normal cytology within 6 months and 65% within 18 months 3
  • Surveillance at 12 months has been shown to be as effective as immediate colposcopy for women who are HPV positive with negative or borderline cytology 4
  • This approach balances the need for follow-up of HPV infection while avoiding unnecessary procedures in women likely to clear the infection spontaneously 1, 4

Prognostic Factors for HPV Clearance

  • Non-smoking status is associated with higher rates of HPV clearance (76% vs 46% in smokers) 6
  • Nulliparity is associated with higher clearance rates (80% vs 44% in parous women) 6
  • Age is also a factor, with younger women generally having higher clearance rates 3

Common Pitfalls to Avoid

  • Don't ignore non-high-risk HPV positivity: While less concerning than high-risk types, follow-up is still necessary 5
  • Don't perform immediate colposcopy: This would be excessive for normal cytology with non-high-risk HPV types 1
  • Don't recommend hysterectomy or excisional procedures: These are unacceptable based on a single positive HPV test 1
  • Don't extend screening interval beyond 12 months for initial follow-up: The first follow-up should be at 12 months to ensure appropriate surveillance 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Negative Pap/HPV Test with Reactive Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.